What is HC Wainwright’s Forecast for ESPR Q3 Earnings?
Esperion Therapeutics, Inc. (NASDAQ:ESPR – Free Report) – Equities researchers at HC Wainwright issued their Q3 2025 earnings per share estimates for shares of Esperion Therapeutics in a report released on Tuesday, March 4th. HC Wainwright analyst J. Pantginis forecasts that the biopharmaceutical company will post earnings of ($0.15) per share for the quarter. HC […]
Esperion Therapeutics, Inc. (NASDAQ:ESPR – Free Report) – Equities researchers at HC Wainwright issued their Q3 2025 earnings per share estimates for shares of Esperion Therapeutics in a report released on Tuesday, March 4th. HC Wainwright analyst J. Pantginis forecasts that the biopharmaceutical company will post earnings of ($0.15) per share for the quarter. HC […]
